In Focus: INSIGHT MM
With the introduction of new drugs with different mechanisms of action, multiple myeloma (MM) patients’ outcomes have improved. However, the efficacy seen in clinical trials is often not seen in real-world settings and data on the effectiveness of MM therapies are needed. INSIGHT MM is a prospective, global, non-interventional, observational study that is enrolling approximately 4200 patients with newly diagnosed or relapsed/refractory MM, making it the largest study of its kind to date.
In this feature, take a look at the key aspects of the INSIGHT MM study and how it could impact routine clinical practice. We also take a peek behind the paper with lead author, Caitlin Costello (University of California San Diego, CA, USA).
Take a look behind the scenes of the recent Future Oncology article as we ask Caitlin Costello about the importance of incorporating real-world evidence into research as well as the importance of the INSIGHT MM study and how the study could effect routine clinical practice.
Our recent In Focus has highlighted INSIGHT MM, a large global, prospective, non-interventional, real-world study of patients with multiple myeloma. This infographic summarizes the protocol’s main aspects.